TY - JOUR
T1 - Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiency
AU - McGlacken-Byrne, Sinéad M.
AU - del Valle, Ignacio
AU - Stabej, Polona Le Quesne
AU - Bellutti, Laura
AU - Garcia-Alonso, Luz
AU - Ocaka, Louise A.
AU - Ishida, Miho
AU - Suntharalingham, Jenifer P.
AU - Gagunashvili, Andrey
AU - Ogunbiyi, Olumide K.
AU - Mistry, Talisa
AU - Buonocore, Federica
AU - Sgene, GO
AU - Crespo, Berta
AU - Moreno, Nadjeda
AU - Niola, Paola
AU - Brooks, Tony
AU - Brain, Caroline E.
AU - Dattani, Mehul T.
AU - Kelberman, Daniel
AU - Vento-Tormo, Roser
AU - Lagos, Carlos F.
AU - Livera, Gabriel
AU - Conway, Gerard S.
AU - Achermann, John C.
N1 - Publisher Copyright:
© 2022, McGlacken-Byrne et al.
PY - 2022/3/8
Y1 - 2022/3/8
N2 - Primary ovarian insufficiency (POI) affects 1% of women and carries significant medical and psychosocial sequelae. Approximately 10% of POI has a defined genetic cause, with most implicated genes relating to biological processes involved in early fetal ovary development and function. Recently, Ythdc2, an RNA helicase and N6-methyladenosine reader, has emerged as a regulator of meiosis in mice. Here, we describe homozygous pathogenic variants in YTHDC2 in 3 women with early-onset POI from 2 families: C. 2567C>G, p.P856R in the helicase-associated (HA2) domain and c.1129G>T, p.E377*. We demonstrated that YTHDC2 is expressed in the developing human fetal ovary and is upregulated in meiotic germ cells, together with related meiosisassociated factors. The p.P856R variant resulted in a less flexible protein that likely disrupted downstream conformational kinetics of the HA2 domain, whereas the p.E377*variant truncated the helicase core. Taken together, our results reveal that YTHDC2 is a key regulator of meiosis in humans and pathogenic variants within this gene are associated with POI.
AB - Primary ovarian insufficiency (POI) affects 1% of women and carries significant medical and psychosocial sequelae. Approximately 10% of POI has a defined genetic cause, with most implicated genes relating to biological processes involved in early fetal ovary development and function. Recently, Ythdc2, an RNA helicase and N6-methyladenosine reader, has emerged as a regulator of meiosis in mice. Here, we describe homozygous pathogenic variants in YTHDC2 in 3 women with early-onset POI from 2 families: C. 2567C>G, p.P856R in the helicase-associated (HA2) domain and c.1129G>T, p.E377*. We demonstrated that YTHDC2 is expressed in the developing human fetal ovary and is upregulated in meiotic germ cells, together with related meiosisassociated factors. The p.P856R variant resulted in a less flexible protein that likely disrupted downstream conformational kinetics of the HA2 domain, whereas the p.E377*variant truncated the helicase core. Taken together, our results reveal that YTHDC2 is a key regulator of meiosis in humans and pathogenic variants within this gene are associated with POI.
UR - http://www.scopus.com/inward/record.url?scp=85125927624&partnerID=8YFLogxK
U2 - 10.1172/jci.insight.154671
DO - 10.1172/jci.insight.154671
M3 - Article
C2 - 35138268
AN - SCOPUS:85125927624
SN - 2379-3708
VL - 7
JO - JCI Insight
JF - JCI Insight
IS - 5
M1 - e154671
ER -